85X0.F BIOEXTRAX AB
- Market cap
- EUR 10.3M
- P/E
- -
- P/B
- 8.93x
- ROE
- -154.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 85X0.F undervalued?
Graham numberThe Graham number of BIOEXTRAX AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIOEXTRAX AB fundamental analysis
No fundamental analysis for BIOEXTRAX AB yet.
BIOEXTRAX AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for…
Full company profileBIOEXTRAX AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BIOEXTRAX AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 276K | 395K | 2.06M | 515K | 757K | 630K |
| Gross Profit | -757K | -950K | 718K | -915K | -501K | -140K |
| Operating Income | -10.5M | -18.7M | -21.6M | -17.5M | -17.8M | -18.6M |
| EBITDA | - | -18.2M | -20.6M | -16.2M | -16.6M | -17.5M |
| Net Income | -10.5M | -18.7M | -21.5M | -17.3M | -17.7M | -18.5M |
| EPS | -0.63 | -0.72 | -0.73 | -0.44 | -0.44 | -0.39 |
| Balance Sheet | ||||||
| Total Assets | 12.6M | 37.9M | 22.5M | 29.0M | 24.7M | 14.5M |
| Total Liabilities | 5.14M | 6.15M | 1.98M | 2.94M | 3.51M | 2.51M |
| Shareholders' Equity | 7.50M | 31.8M | 20.5M | 26.1M | 21.2M | 12.0M |
| Cash & Short-term Investments | 8.98M | 27.5M | 13.4M | 17.3M | 3.93M | 7.39M |
| Cash Flow | ||||||
| Operating Cash Flow | -8.48M | -17.6M | -23.3M | -18.8M | -26.0M | 7.26M |
| Capital Expenditure | 975K | 6.78M | 1.10M | 215K | 152K | 342K |
| Free Cash Flow | -9.45M | -24.4M | -24.4M | -19.0M | -26.2M | 6.92M |
| Ratios | ||||||
| ROE | -140.4% | -58.8% | -104.7% | -66.5% | -83.5% | -154.2% |
| ROA | -83.3% | -49.2% | -95.5% | -59.8% | -71.6% | -127.5% |
| Net Profit Margin | -3,815.9% | -4,725.8% | -1,046.1% | -3,366.6% | -2,338.8% | -2,932.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BIOEXTRAX AB dividends
BIOEXTRAX AB has not paid dividends in the last 5 fiscal years.
Last stock split: 4:1 on Jul 22, 2021.
Who owns BIOEXTRAX AB
- Insiders 21.81%
- Institutions 22.60%
- Public & others 55.59%
- Shares outstanding 47.7M
- Free float 39.3M
BIOEXTRAX AB company profile
- Company name
- BIOEXTRAX AB
- Ticker
- 85X0.F
- ISIN
- SE0016276752
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Employees
- 14
- Fiscal year end
- December
- Address
- Skiffervägen 76, Lund, Sweden, 224 78
- Phone
- 46 7 36 26 76 43
- Website
- bioextrax.com
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for composites, agriculture, filtration, padding, textiles, and more. Bioextrax AB (publ) was incorporated in 2014 and is based in Lund, Sweden.
BIOEXTRAX AB management
4- Mr. Edvard HallChief Executive Officer · born 1985
- Mr. Mohammad H. A. Ibrahim Ph.D.Founder & Advisor · born 1977
- Mr. Kristofer SvenssonChief Financial Officer · born 1982
- Mr. Klas IngstorpChief Operating Officer · born 1971